Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 258

1.

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.

Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN.

Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00355-19. doi: 10.1128/AAC.00355-19. [Epub ahead of print]

2.

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.

Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94. doi: 10.1093/ofid/ofy358. eCollection 2019 Mar.

3.

Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States.

Mendes RE, Jones RN, Woosley LN, Cattoir V, Castanheira M.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S69-S78. doi: 10.1093/ofid/ofz004. eCollection 2019 Mar.

4.

Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016.

Shortridge D, Gales AC, Streit JM, Huband MD, Tsakris A, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S63-S68. doi: 10.1093/ofid/ofy343. eCollection 2019 Mar.

5.

Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016.

Pfaller MA, Cormican M, Flamm RK, Mendes RE, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S54-S62. doi: 10.1093/ofid/ofy344. eCollection 2019 Mar.

6.

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program.

Diekema DJ, Pfaller MA, Shortridge D, Zervos M, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S47-S53. doi: 10.1093/ofid/ofy270. eCollection 2019 Mar.

7.

Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).

Gales AC, Seifert H, Gur D, Castanheira M, Jones RN, Sader HS.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S34-S46. doi: 10.1093/ofid/ofy293. eCollection 2019 Mar.

8.

Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program.

Castanheira M, Deshpande LM, Mendes RE, Canton R, Sader HS, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33. doi: 10.1093/ofid/ofy347. eCollection 2019 Mar.

9.

Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016).

Sader HS, Mendes RE, Le J, Denys G, Flamm RK, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S14-S23. doi: 10.1093/ofid/ofy263. eCollection 2019 Mar.

10.

Antimicrobial Resistance Surveillance and New Drug Development.

Sader HS, Rhomberg PR, Fuhrmeister AS, Mendes RE, Flamm RK, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S5-S13. doi: 10.1093/ofid/ofy345. eCollection 2019 Mar.

11.

The Importance of Antimicrobial Resistance Monitoring Worldwide and the Origins of SENTRY Antimicrobial Surveillance Program.

Fuhrmeister AS, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S1-S4. doi: 10.1093/ofid/ofy346. eCollection 2019 Mar.

12.

Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014).

Pfaller MA, Flamm RK, Duncan LR, Mendes RE, Jones RN, Sader HS.

Diagn Microbiol Infect Dis. 2017 Jun;88(2):177-183. doi: 10.1016/j.diagmicrobio.2017.02.020. Epub 2017 Mar 6.

PMID:
28341098
13.

Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.

Sader HS, Castanheira M, Mendes RE, Flamm RK, Jones RN.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02409-16. doi: 10.1128/AAC.02409-16. Print 2017 Apr.

14.

Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015.

Castanheira M, Griffin MA, Deshpande LM, Mendes RE, Jones RN, Flamm RK.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5623-4. doi: 10.1128/AAC.01267-16. Print 2016 Sep. No abstract available.

15.

Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).

Sader HS, Castanheira M, Farrell DJ, Flamm RK, Mendes RE, Jones RN.

Int J Antimicrob Agents. 2016 Aug;48(2):144-50. doi: 10.1016/j.ijantimicag.2016.04.021. Epub 2016 May 24.

PMID:
27291285
16.

Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).

Jones RN, Schuchert JE, Mendes RE.

Antimicrob Agents Chemother. 2016 May 23;60(6):3419-25. doi: 10.1128/AAC.00116-16. Print 2016 Jun.

17.

In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients.

Flamm RK, Nichols WW, Sader HS, Farrell DJ, Jones RN.

Int J Antimicrob Agents. 2016 Mar;47(3):235-42. doi: 10.1016/j.ijantimicag.2016.01.004. Epub 2016 Feb 3.

PMID:
26920105
18.

Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.

Costello SE, Gales AC, Morfin-Otero R, Jones RN, Castanheira M.

Microb Drug Resist. 2016 Jun;22(4):253-8. doi: 10.1089/mdr.2015.0168. Epub 2015 Dec 30.

PMID:
26716768
19.

Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.

Deshpande LM, Ashcraft DS, Kahn HP, Pankey G, Jones RN, Farrell DJ, Mendes RE.

Antimicrob Agents Chemother. 2015 Oct;59(10):6256-61. doi: 10.1128/AAC.01473-15. Epub 2015 Jul 27.

20.

Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).

Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN.

Diagn Microbiol Infect Dis. 2015 Oct;83(2):183-6. doi: 10.1016/j.diagmicrobio.2015.06.011. Epub 2015 Jun 23.

PMID:
26164275

Supplemental Content

Loading ...
Support Center